ArticleInternational journal of clinical and experimental medicine2013

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk.

Luqian Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.